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A B S T R A C T   
The polysaccharide-based advanced drug delivery system owing to their biocompatibility, ability to encapsulate 
the drug molecules in their interspaces, and ability to achieve a controlled release of the cargo drug molecules 
result in improved drug pharmacokinetics. The drug-loaded polysaccharides possess ability to evade the 
multidrug-resistant microbial efflux pumps by aggregation effect, whereas the drug loaded polysaccharide- 
fabricated metal nanoparticles present an exceptional candidature for effectively transporting the drug mole-
cules across the membrane barriers while enabling the theranostic applications at the same time. The biode-
gradability of polysaccharide based drug delivery systems ensure a sustained release of the encapsulated drug 
molecules, which minimizes the side effects caused by a burst release of the cargo therapeutics. These drug 
delivery systems proved highly beneficial for the NSAIDs that otherwise manifest ulcerogenic effect in the 
gastrointestinal tract. The large surface area of polysaccharides further provide a higher drug-loading capacity, 
which maintains the optimal concentration of the cargo drug at the target sites. The emerging applications of 
biodegradable polysaccharides in the designing of multicompartmental microspheres revolutionized tissue en-
gineering, multi drug delivery, and cell culturing technologies. The present review deals with the current-status 
of polysaccharides as advanced drug delivery systems.   
1. Introduction 
Polysaccharides comprise of repeated mono- or disaccharide units 
connected via enzyme-susceptible glycosidic bonds, which support their 
applications as controlled release drug carriers. Their remarkable 
physicochemical and physiological properties such as biocompatibility, 
biodegradability and low immunogenicity [1–4] further validate the 
drug delivery applications. Usually, such natural polysaccharides are 
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easily available from the plant, animals and microbes. Such poly-
saccharides possess various physicochemical properties such as being 
neutral or having positive or negative charge, being able to have linear 
or branched molecular structure, and their molecular weight can vary 
from a few hundred to several thousand Daltons [5–7]. Due to these 
properties, the polysaccharides have considerable impact on the bio-
distribution of carrier drug molecules in-vivo [8,9]. 
Numerous polysaccharides could even adhere to the layer of mucus, 
which covers epithelial surfaces throughout the body. Thus, the poly-
saccharide based carrier systems have extended in vivo residence time in 
gastrointestinal (GI) tract, thereby increasing drug bioavailability 
[10–14]. Cationic polysaccharides such as chitosan and its derivatives 
have the capacity to open the tight interconnections among epithelial 
cells, thereby increased hydrophilic drug permeability through mucus 
membranes [15–20]. 
The polysaccharides possess an inherent ability to recognize specific 
receptors, which over-express on the surface of morbid tissues. As such, 
hyaluronic acid specifically binds to the over-expressed CD44 receptor 
of several tumor cells [21]. In addition, pullulan reportedly possesses a 
high specificity towards asialoglycoprotein receptors that express at the 
surface hepatocytes [22]. The unique binding of these polysaccharides 
with certain receptors permits a rational designing of novel carriers, 
which selectively deliver the cargo drugs by means of receptor-mediated 
endocytosis [23–26]. 
Besides, the natural polysaccharides offer advanced applications as 
multi-drug delivery systems. 
In this review, we present a comprehensive survey of the advanced 
applications of Polysaccharides in drug delivery and other biomedical 
applications and the various factors that determine the efficacy of these 
applications. 
2. Physicochemical factors 
The alterations and chemical modifications of the functional head 
groups such as –COOH, –NH2, and –OH on the polysaccharide 
structures led to the generation of polysaccharide derivatives with 
distinct properties for specific applications. Reportedly, the sulfonation 
of Pullulan ameliorates its anticoagulant activity compared to the non- 
sulphated counterpart. Whereas the thiolation of chitosan significantly 
improves its mucoadhesive properties compared to the non-thiolated 
counterpart [27,28] owing to the formation of tight covalent bonds 
with cysteine-rich mucus glycoprotein subdomains by the former 
[29,30]. 
The interactions with functional head groups on polysaccharides 
enables the incorporation of therapeutic drugs into the main chain 
through covalent bonds or electrostatic interactions followed by subse-
quent release of the incorporated drug at target site under a suitable 
stimuli [31,32]. Similarly, the amphiphilic derivatives of poly-
saccharides prepared by tethering the hydrophobic moieties to the 
parent chain possess self-assembly properties in physiological settings 
and present applications for the delivery of hydrophobic drug molecules 
such as paclitaxel to the target cells [33–36]. 
Zeta potential also plays an important role in the drug delivery ap-
plications by polysaccharides by influencing the interactions of poly-
saccharide nanosystems with proteins and cells [37]. The factors that 
generate a net charge on the surface of polysaccharide nanocarrier 
contribute towards the production of a high zeta potential. The disso-
ciation of ionogenic surface group or adsorbed molecules, and the 
presence of other ions in parent solvent or on the surface of the molecule 
offer a significant contribution towards the zeta potential of non- 
ionogenic polysaccharides. However, when the aqueous medium has 
no other electrolytes, the hydroxide ions adsorb on the surface of 
polysaccharide resulting in an overall negative surface load [38,39]. 
The pH value of the medium in addition to the ionic strength, particle 
size and particle density considerably influence the zeta potential 
[40–42]. Acidic pH promotes the adsorption of protons due to increasing 
concentration (the zeta potential increases) while a reverse effect takes 
place at basic pH due to the elevated concentration of hydroxide ions. At 
a certain pH level, the zeta potential may become zero, leading to 
instability in the colloids and accumulation of particles. Increasing 
electrolyte rates in the parent medium usually result in the shielding of 
electrical charges. This result in to the compression of the electrical 
double layer that contributes to less electrostatic repulsion and colloid 
coagulation [43–45]. 
The phosphorylated chitosan-based micelles have been studied for 
their effect on mucosal drug delivery during the change in zeta potential. 
On contacting the alkaline phosphatase (cell surface glycoproteins found 
in many organs such as the intestine, the lungs and the vagina), the 
phosphorylated micelles undergo a split off to make the zeta potential 
from negative to positive or neutral [46–48]. An initial negatively 
charged surface enables the micelles to resist the binding of poly-
saccharide to negative charged components of the mucus and diffuse 
through the layer of the mucus. Whereas, a subsequent positive charge 
enhances the contact of polysaccharide with mucus and cell membranes 
thereby preventing the back diffusion, cellular premising and internal-
ization [49,50]. 
Biodegradable polysaccharides or biopolymer-based nanomaterials 
disintegrate during their intended function in physiological settings 
[51]. These polymers degrade in situ to generate the natural by-products 
such as water, carbon dioxide, and small organic molecules [52]. The 
backbone of these polysaccharides include functional groups of ester, 
amide, and ether that undergo enzymatic degradation in physiological 
environment [53]. Their structure and composition dictates the mech-
anisms of their degradation [54–56]. 
The backbone of polymeric materials consists of chemical bonds 
including polyesters, polyamides, and polyanhydrides that offer 
numerous implementations. The polymeric materials composed of car-
bohydrates consists of large chains of monosaccharide units that by 
hydrolysis produce the monosaccharide portion or the oligosaccharide 
component. Their constructions vary from linear to highly branched 
polymers. Minor differences in polysaccharide molecules can lead to a 
substantial difference in the properties [57]. As such, even the minor 
stereochemical differences in starch and cellulose result dramatically 
different functions. Click chemistry and radical polymerization tech-
niques bind several polymers to the cellulose backbone due to the 
presence of several functional head groups on the polymeric backbone. 
Especially, the green polysaccharides have been of recent interest 
because their biodegradability and the materials based on these poly-
saccharides are ideal for absorption and subsequent removal from the 
body and the systemic circulation. Interestingly, the 500 odd species of 
bacteria in the intestinal tract make this environment an exceptional 
microbial ecosystem. The gut microbiota conduct a simple series of 
biochemical processes involving starch breakdown, vitamin synthesis, 
and fermentation, while the polysaccharide oxidation happens in the 
intestines [58]. A great deal of research has been done focused on 
alkaline polysaccharide degradation based primarily on 100 ◦C or less 
temperatures to evaluate processes of degradation, kinetics of degra-
dation, and interactions between structural composition and environ-
ment [59–63]. 
The polysaccharides do not convert into acids at low temperatures, 
while in an alkaline solution, both the starch and cellulose thermo-
chemically degrade to water-soluble compounds [64,65]. These prop-
erties support the colon-targeted release of the cargo drug molecules and 
prevent their premature release in the acidic pH of the stomach [66]. 
Mainly, the alkaline degradation of starch provides products such as 
starch and cellulose, in addition to small organic compounds such as 
acetic acid, formic acid, lactic acid, glycolic acid, 2-hydroxyvaleric acid, 
and 2-hydroxybutyric acid. The second-order kinetics with the Arrhe-
nius equation for reactivating energy of 165 kJmol− 1 explains the decay 
of starch and cellulose in alkaline solution [67]. The thermal decom-
position investigations of polysaccharides calculated utilizing a slit 
viscometer for sodium alginate, carrageenan, and carboxymethyl 
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cellulose (CMC) was reported with results indicating alginate to be much 
less robust than CMC and carrageenan [68–69]. The activation energy 
for carrageenan reportedly appeared as 104 kJmol− 1, while alginate 
displayed 50.7 kJmol− 1 activation energy, with CMC to be 79.9 kJmol− 1 
[70]. 
3. Biotolerance 
A major attribute to PS-based nanomaterials, in addition to their 
biocompatibility, is their physiological tolerance towards the live cells. 
Polysaccharides reportedly exhibit strong propensity to aggregate based 
on the concentration of hydroxyl or amino groups involved in hydrogen 
bonding within the macromolecules. The reversible interactions pri-
marily happen at increased concentrations of the polysaccharide and 
decreases again after the sample dilution. Further, the polyelectrolyte 
concentration significantly effects the multilayered structure and the 
density of the polysaccharide materials. Reportedly, the polysaccharide 
concentrations between 0.1% and 0.5% play a significant role in the 
construction of multilayered structures [71–75]. The charge on poly-
saccharide surface determine the aggregation of their colloidal solutions 
where different surface charges are liable for multiple polysaccharide 
behaviors. The pH and the ionic intensity of the media further influence 
ionization levels of the polysaccharides, and hence the complex forma-
tion and phase segregation of low polyelectrolytes are generally asso-
ciated with polysaccharide-based nanomaterials [76]. 
3.1. Effect of pH 
Within the last few decades, the pH-dependent swelling-shrinking 
induced behavior resulted in the formation of new polysaccharide NPs 
that received significant interest in drug delivery [77,78]. The stimuli- 
responsive therapeutics release rely on different interactions induced 
by the aqueous property, polymeric backbone, and pharmaceutical 
structural composition [79–82]. Researchers, therefore, evaluated the 
swelling behavior of polysaccharide NPs in buffer solutions of various 
pH values and reported that the swelling efficiency increased with pH 
value, indicating clearly that polysaccharides NPs present a good 
candidature for a drug carrier with the ability to sense variation in 
surrounding pH. Several polysaccharides exhibit an outstanding toler-
ance towards wide pH conditions, salt concentrations, while displaying 
an excellent thermal stability [83]. Depending on the gastrointestinal 
(GI) secretions, the rationally designed sustained-release formulations of 
polysaccharides depend on pH of the environment, and cationic charge 
[84–85]. As such, the carboxy groups present on the polysaccharide 
offered pH-sensitivity to the dextran-based NPs. Zhang and coworkers 
documented unique pH- and aqueous-force-sensitive hydrogel mem-
branes wherein pH-dependent swelling appeared in the acidic side 
chains of the polysaccharides [86–87]. More recently, by grafting syn-
thetic poly(acrylic acid) copolymer (D-A copolymer) on dextran, the 
researchers designed an altered copolymer that displayed biotolerance, 
biodegradability, biocompatibility and pH-sensitivity. This 
polysaccharide-based system effectively delivered Ibuprofen in the 
phosphate buffer solution (PBS) at pH 2.0 and pH 7.4. The findings 
further indicated the pH-responsiveness of copolymer, which enhanced 
with increase in the molar ratio of AA/dextran [88]. 
3.2. Effect of ionic strength 
Another variable that affects the particle size is the ionic strength of 
the solvent and the concentration gradient that plays a significant role in 
designing the materials with drug delivery applications [89]. The 
alternative crystalline structure and amorphous cellulose structure 
(contributing to stability and plasticity) offer a lower rigidity to the 
resulting nanofibrils at high ionic strength [90]. At moderate ionic 
strength, the polysaccharides-based nanomaterials promote stem cell 
replication without inducing cytotoxicity or inflammatory effects in vivo 
[91]. Polysaccharide based nanomaterials are often responsible for in 
vitro anti-inflammatory effects on human keratinocytes [92]. One of the 
critical elements to evaluate the tolerance of the immune system to-
wards polysaccharide-based drug delivery systems is through the eval-
uation of dendritic cells (DCs), which are the central inherent immune 
cells that regulate the immune response to specific nanomaterials [93]. 
DCs can also promote immune resistance by producing ILT 3, ILT4, 
indoleamine-dioxygenase (IDO)-1, and cytokine IL-10. Inflammatory 
and regulatory populations of T cells may also contribute to the regu-
lation of inflammatory diseases. The DCS are the primary goal in diag-
nosis with tumors, infectious disorders, persistent inflammatory 
problems, implant recognition, and wound repair [94–96]. The 
polysaccharide-based nanomaterials reportedly induce adequate im-
mune tolerance by recruiting the differential human DCs that can down- 
regulate Th1 and Th17 cells and up-regulate Th2 and Treg in vitro 
[97–99]. 
4. Theranostics 
The application of biodegradable polysaccharides for an effective 
drug delivery and bioimaging of the drug activity in the target morbid 
tissues is becoming rapidly desirable. The biodegradable natural poly-
mers based on polysaccharides present extensive applications as tablet 
binders and viscosity liquid or emulsifying agents. The polysaccharides 
used as coating agents ensure the avoidance of an undesirable product 
flavor, enhancement in medication safety as well as improvements in 
pharmaceutical volume, and release rate [100]. The short half-life of 
deliberated pharmaceuticals requires multiple injections or doses, which 
continues to raise adverse effects and medication expenses. In the case of 
poor patient adherence, multiple dosing is also problematic. To solve 
these issues, the process of drug delivery to patients improved by adding 
biodegradable polymers for medication encapsulation [101]. The 
crosslinking of the cargo pharmaceutical with biodegradable polymer 
releases on a continuous or regulated basis from the encapsulating 
polysaccharide. Mainly, the extent of crosslinking in the encapsulating 
polysaccharide material determines the release profile of cargo drug 
molecules. The placement of the cargo pharmaceutical into a hydrogel 
such as CMC polymer generates several pores created by hydrolysis and 
other ways of degradation, which allows a controlled release of the 
cargo drug [102]. 
4.1. Polysaccharide-based contrast agent 
For engineered polysaccharide-based NPs as theranostic nano-
materials, the efficacy depends on the route of operation, retention 
period and the form of imaging and therapy. The selected poly-
saccharides and their key characteristics, including the size, and struc-
ture poses a significant impact on the theranostic applications. The 
amphiphilic polysaccharides containing stimuli-labile linkers or hydro-
phobic moieties serve as a useful theranostic material [103]. Bio- 
reducible disulfide connectivity cleavable in the intracellular environ-
ment prepared by chemical modification of Carboxymethyl dextran 
(CMD) to lithocholic acid presented interesting theranostic applications 
[104]. In another study, doxorubicin released in PBS with 10 mm of 
glutathione, a tripeptide that intracellularly reduces disulfide bond in 
selective and robust polynomial nanomaterials [105]. The reported 
nanomaterial improved the biodistribution of the cargo drug in tumor 
cells as indicated in the labelling experiments. As a result, antitumor 
efficacy in vivo of DOX-loaded NPs was considerably higher in compar-
ison to reduction-insensitive NPs of CMD [106]. Furthermore, cucurbit 
[6] uril-conjugated to (CB [6]-hyaluronate) was developed as a model of 
the desired imaging system (Jung, Park et al. 2011). The decoration of 
this complex framework with FITC-spermidine (spmd) and/or the 
formyl-peptide receptor-like 1 (FPRL1) resulted in the formation of 
(FITC-spmd and/or peptide-spmd)@CB[6]-HA nanosystem used effec-
tively to image its target-specific delivery in human breast 
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adenocarcinoma cells (FPRL1 / MCF-7) with elevated Ca2+ and 
phosphorus-extracellular signal-regulating kinase (pERK) [107]. Qu 
et al. reported advanced delivery system based on the nanocellulose- 
containing microparticles that offered ROS-trigger release of doxoru-
bicin. The microparticles consisted of light-sensitive shell containing 
Indocyanine green, which generated ROS on near infrared laser irradi-
ation, eventually causing the degradation of cellulose nanocrystals 
present in the microparticles [108]. This bioinspired system based on 
ROS-mediated wood degradation by brown-rot fungi possessed minimal 
toxicity and non-immunogenicity that further validated its drug delivery 
applications. Further advancements led to Gas-shearing fabrication of 
multicompartmental microspheres obtained from water-soluble cellu-
lose acetate, ethyl-cellulose, and cellulose-acetate-phthalate. The utility 
of biodegradable polysaccharides instead of the oils and surfactants for 
the generation of monodisperse multicompartmental microspheres led 
to the achievement of cytocompatibility by the microparticles. In addi-
tion, the oil-free gas-shearing process allowed the design of micropar-
ticles up to eight compartments with a precise control over the 
properties of each of these compartments. These microspheres offered 
applications in biomedical engineering due to their ability to carry 
multiple materials in separate phases. These microparticles presented 
applications as multidrug delivery vehicles, multitarget detection, 
multienzyme tandem reactions, and in cell culturing technologies. The 
robust candidature of these microparticles in tissue engineering resolves 
the key challenges associated with cellular delivery in the current 
bioengineering paradigm [109]. The recent fabrication of coaxial elec-
trospun core-shell fibers based on cellulose acetate offer a sustained 
release of the biological compounds necessary for promoting plant 
growth, and promote tissue healing in plants. The impregnation of these 
fibers with polyurethane provides mechanical strength and enhances the 
modulus of elasticity that further result in the development of plant 
wound dressings. Initially, the core-shell fibers displayed 50% release of 
the encapsulated material in 72 h, followed by a slower release that 
occurred mainly due to the hydrophobic nature of cellulose acetate. This 
release profile however discouraged the sustained release application of 
core shell fibers. The hydrophilicity of cellulose acetate and hydropho-
bicity of coaxial polyurethane caused the loading of cargo drug in the 
latter due to the poor affinity of the drug with water. Notably, the 
encapsulated drug displayed two-stage release kinetics from the cellu-
lose acetate-polyurethane coaxial electrospun fibers [110]. 
Superparamagnetic iron oxide nanoparticles possess characteristic 
magnetic properties for bioimaging applications. Their coating with 
polysaccharides provide robust drug delivery materials with theranostic 
applications [111,112]. Furthermore, as an innovative method for 
achieving a controlled drug delivery and bioimaging applications, 
superparamagnetic iron oxide nanoparticles coated with hyaluronan 
(HA) (HA-FeO). The target cancer cells rapidly uptake HA-FeO nano-
system on incubation for 24 h [113], and HA-FeO internalization into 
the cancerous cells was far higher than NPs without HA fabrication. 
Notably, the high magnetic relaxation and increased utilization of HA- 
FeO promote cancerous cell imaging. The anchoring of DOX via an 
acid-responsive linker to the NPs further promoted a controlled release 
of the drug. DOX-HA-FeO system was far more potent than free DOX in 
offering therapeutic properties against the multidrug-resistant cancer 
cells [114]. Choi et al., identified the simultaneous delivery platform for 
the gene/drug, and tumor by using chitosan functionalized magnetic 
graphene (CMG). The nanosystem provided a robust candidature as T2 
contrast-improving agent as indicated by the phantom tube experiments 
and ex vivo MRI. As measured by the WST method, CMGs concentrated 
mostly on the tumor cells, as demonstrated by distribution studies and 
MRI [115]. Heparin-folic-IR-780 (HF-IR-780) multifunctional NPs syn-
thesized by self-assembly through an ultrasonic sound method specif-
ically targeted the tumor cells while providing the bioimaging 
applications. Assays on in vitro cell viability and photothermal in vivo 
therapy show a mixture of HF-IR-780 NPs with 808 nm laser radiation in 
the shape of MCF-7 or xenograft MCF-6 cell tumors [116]. Glycolated 
chitosan based Bcl-2 siRNA complex provided applications in gene 
therapy in addition to providing theranostic applications for the imaging 
of solid tumors. Further, the polysaccharide-based nanomaterial assisted 
the targeted delivery of doxorubicin to the target cancer cells [117]. 
4.2. Polysaccharide-based drug delivery systems 
The differential pH gradient between the tumor and healthy tissues, 
as well as between cytoplasm and endosome serves as essential stimuli 
for smart drug delivery applications. The four specific approaches uti-
lized to design the pharmaceutical carriers include drug conjugated to 
the polysaccharide, entrapment of therapeutics through in aerogels and 
hydrogels, formulation of drug-loaded polysaccharide nanoparticles 
(NPs) through the self-assembly. Fig. 1 highlights the various types of 
interactions between the drug molecule and polysaccharides. (See 
Table 1.) 
5. Modification of polysaccharides 
5.1. Physical interactions 
Polysaccharide molecule containing functional head groups on their 
surface undergoe chemical modification for conjugating with the 
desired drug molecules [118]. Specifically, the –OH group present on 
the polysaccharide undergoes esterification or etherification with acyl-
ating and alkylating agents respectively [119–120]. This group un-
dergoes further oxidation to –COOH and –CHO groups in the presence 
of a suitable oxidizing agent that further extends the chances of conju-
gation with a diverse range of functional groups on the cargo molecule. 
The –COOH group and –NH2 functionalities in polysaccharides un-
dergo amidation, hydrazone formation, and Schiff base modification to 
conjugate with the cargo drug molecules [121–123]. Typically, the 
formation of polysaccharide gel requires a chemical or physical cross- 
linking of the polysaccharide for encapsulating the therapeutic mole-
cules [124–127]. Mainly, the physical cross-linking of polysaccharides 
involves simpler preparation protocols devoid of chemical reagents 
[128]. The polysaccharides containing –COOH or –NH2 groups 
reportedly undergo ion complexation to generate the physically cross- 
linked nanohydrogels with myriad applications as drug delivery vehi-
cles [129]. Typically, the anionic polysaccharides generate hydrogels by 
interacting with metal cations, while the cationic polyglucosamines 
interact with multivalent metal anions [130–131]. Similarly, the nega-
tively charged alginic acid displays cross-linking interactions with 
CaCl2, whereas the positively charged chitosan readily interacts with 
sodium tri-polyphosphate [132–134]. Notably, the carrageenan poly-
saccharides contain sulfonate group along their backbone that serve as a 
site for cross-linking with metal ions as well as cationic polymers such as 
chitosan [135–137]. 
The interactions between the dissimilarly charged polymers result in 
the formation of polyelectrolyte complex [138]. Mainly, the ionic in-
teractions in the polyelectrolytes exhibit a superior strength compared 
to the van der Waals forces and hydrogen bonding interactions [139]. 
The negatively charged polysaccharides including hyaluronic acid, 
pectin, xanthan, carboxymethyl cellulose, alginic acid, and chondroitin 
sulfate form the polyelectrolytes [140–142]. In addition, the proteins 
such as albumin, gelatin, collagen, keratin, and synthetic polyacrylic 
acids reportedly generate polyelectrolytes [143]. 
Hydrophobic interactions result in the physical cross-linking of 
polysaccharides for maintaining the structure and morphology. The 
anchoring of hydrophobic groups to the polysaccharide chain lower the 
water solubility and promote hydrophobic drug delivery [144]. The 
amphiphilic copolymers prepared by entrenching the hydrophilic 
polymeric backbone with hydrophobic structures, orient themselves to 
achieve a minimum free energy state, while the hydrophobic portion 
disengage from the aqueous environment thereby forming core shell 
structure of polymeric micelles [145]. The structures containing 
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hydrophilic outer shell enclosing the hydrophobic interior serve as 
carrier for hydrophobic drug molecules [146]. The modification of 
polysaccharides with long chain fatty acids such as palmitic acid, stearic 
acid, linoleic acid, linolenic acid, and hexanoic acid result in the gen-
eration of polymeric micelles [147–148]. Similarly, the conjugation of 
polysaccharides to hydrophobic polymers such as poly (εcaprolactone), 
poly (isobutyl cyanoacrylate), poly (ethylene glycol) derivatives, and 
pluronic copolymers generated the desired core-shell drug delivery 
systems with hydrophobic core and hydrophilic shell [149]. Neverthe-
less, the presence of polar groups such as –OH, –COOH, –NH2 in 
polysaccharides participate in hydrogen bonding interactions that play a 
critical role in drug delivery applications. The polysaccharides such as 
chitosan forms hydrogen bonds at pH > 5, whereas it requires low 
temperature and pH to form hydrogen bonding in agarose [150]. 
Similarly, the synthetic polysaccharide carboxymethyl cellulose dem-
onstrates pH sensitive hydrogen bonding interactions, which form the 
basis of drug delivery applications in these polymeric systems [151]. 
5.2. Chemical modifications 
The chemical modification of polysaccharides led to their conjuga-
tion with drug molecules via functional head groups through the cova-
lent bonds. These chemical modifications followed by a subsequent 
conjugation mainly occur via nucleophilic replacement of the saccharide 
oxygen by heteroatomic nucleophiles. Typically, a saccharide electro-
phile possesses lower reactivity towards the nucleophilic substitution 
compared to the other hydrocarbon-derived molecules [152]. The 
destabilization of carbocation generated at the primary or secondary 
position due to the presence of surrounding electron withdrawing –OH 
groups increases the difficulty of SN1 reaction at the primary and sec-
ondary positions, as compared to the SN2 reactions at the same position 
[153]. 
The bulkiness of the alkoxy and acyloxy substituents further lower 
the reactivity of saccharide- derived electrophiles towards SN2 reactions 
[154]. Especially, the higher stability of the chair conformation of the 
six-membered saccharide ring and the presence of multiple equatorial 
substituents makes it difficult for the completion of an SN2 attack the 
secondary position of the target saccharide [155]. Mechanistically, the 
formation of SN2 transition state involves changes in the ring confor-
mation for accommodating the attacking nucleophile, and the leaving 
group around the central carbon. However, the highly stabilized chair 
conformation refuses to undergo these conformational changes as it 
results in less favored strained conformation [156]. 
The replacement of primary and secondary –OH groups in saccha-
ride molecules with a good leaving group improves the susceptibility of 
electrophilic carbon towards the nucleophilic attack. Mainly, the halide 
ions, and the less reactive functional groups such as phosphonate and 
sulfonate prove better leaving groups at the primary position. While the 
groups such as triflates and epoxides serve as better leaving groups at the 
secondary position. The nucleophilic reaction by a saccharide nucleo-
phile through the ‘O’ atom result in the acylation or alkylation of the 
polysaccharide, whereas the nucleophilic attack on polysaccharide 
molecules by alcohols or carboxylates for the formation of ether and 
esters occur less commonly [157]. The esterification of polysaccharides 
occurs preferably via Mitsunobu reaction, which incorporates an in situ 
activation of the -OH group by phosphonium leaving group, where the 
attacking nucleophile facilitates its departure [158]. The high-yielding, 
regioselective Mitsunobu reactions mainly occur at the primary position 
of unprotected saccharide units [159]. Amine group acts as neutral 
nucleophile for modifying the polysaccharide with alkyl chains. Pref-
erably, the monovalent properties of the azide nucleophiles prevent the 
multiple side reactions or cross linking of the parent polysaccharide. The 
azide functionalization of polysaccharides proves highly beneficial for 
their click conjugation to the drug molecules or biomolecules bearing a 
propargyl substituent [160]. The click conjugation of polysaccharides 
with desirable drug molecules via strong triazole spacer improves the in 
Fig. 1. The types of interactions between the polysaccharides and drug molecules.  
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Table 1 
Polyaccharides in drug delivery applications.  
PS-based polymer Therapeutic agents & type of 
targeting 
Cell types Model of 
study 
Polymer advantages References 





Biocompatible, pH stimuli-responsive, down- 
regulate Cyclooxygenase COX-2 genes in tumor 
cells 
[215] 
Dextran- folic acid DOX/Active Breast cancer cell line (4 T1) In vitro 
and in 
vivo 
Reducing the side effect of DOX, enhanced tumor 
growth inhibition, and prolonged survival rate 
[216] 





Enhanced cellular uptake, prolonged 
pharmacokinetics (prolonged circulation time 
and slower elimination), enhanced tumor growth 
inhibition 
[216] 
Dextran-albumin Paclitaxel/ Passive Colorectal cell line (CT-26) In vitro 
and in 
vivo 
Cellular proliferation enhanced inhibition, 
inducing apoptosis, Enhanced drug circulation 
times 
[217] 
Dextran-folic acid Resveratrol/ Active Lung cell line (A549) In vivo Enhanced cellular apoptosis and drug intake [218] 
Dextran-DOX Doxorubicin/ Passive Lymphoma cell lines In vitro 
and in 
vivo 
Reduced cytotoxicity (cardiac), enhanced 
apoptosis, enhanced intracellular intake leading 
to increased DOX concentration that inhibits 
tumor growth 
[219] 
Hyaluronic acid- Chitosan 5-Fluorouracil/ Active Lung cell line (A549) & liver 
cell line (HepG2) 
In vitro Enhanced cell apoptosis and cellular drug 
accumulation 
[220] 
Hyaluronic acid- Poly-lactic-co- 
glycolic acid; 





Prolonged pharmacokinetics, Enhanced cellular 
accumulation 
[221] 
Hyaluronic acid- Poly-lactic- 
co-glycolic acid; 
Paclitaxel/Active Breast cancer cell line (MDA- 
MB-231) 
In vitro Decreased the IC50 of paclitaxel significantly [73] 
Hyaluronic acid- Poly- 
ε-caprolactone-Chitosan 
Naringenin/Active Lung cancer cell line (A549) In vitro 
and in 
vivo 
Enhanced cell apoptosis, increased drug intake 
resulting in inhibiting cancer growth 
[222] 





Enhanced cancer growth suppression, increased 
intake and drug accumulation 
[223] 
Hyaluronic acid Doxorubicin & Gemcitabine 
/Active 
Breast cancer cell lines (MDA- 




Dual modality drug delivery system, enhanced 




Doxorubicin & Cisplatin 
/Active 
Breast cancer cell lines (MDA- 









TWIST- siRNAs (Basic helix- 
loop-helix transcription 
factors)/ Active 





Reduced cancer growth and cell survival through 
selective targeting 
[226] 
Hyaluronic acid-Silica 5-Fluorouracil /Active Colon cancer cell line (HT29) In vitro 
and in 
vivo 
Tumor repression, high cytotoxicity and high 
accumulation in the tumor through selective 
targeting 
[227] 
Chitosan- N-acetyl histidine 
and arginine 
DOX/Passive Breast cancer cell lines MCF-7 In vitro Enhanced cytotoxicity and cellular uptake [228] 
Chitosan- Trimethyl and folate DOX & IL-2/Active Lung cancer cell line (A549), 
Liver cell line (SMMC-7721) 




Increase IgG expression levels, Increased 
cytotoxic T lymphocytes 
[229] 





Inhibit Breast and lung metastasis [230] 
Chitosan- 
Carboxymethyldextran 
DOX and IL17RB siRNA/ 
Passive 
Breast cancer cell line (MDA- 
MB361) 
In vitro Decrease tumor cellular viability, inhibits growth, 
tumor cells migration, and proliferation 
[231] 
Chitosan- Hyaluronic acid- 
sulfobutyl-ether- 
β-cyclodextrin 
Curcumin/Passive Colon cancer cell line (HT29) In vitro Enhanced cellular uptake, reduced cellular 
proliferation, and high toxicity 
[232] 
Alginate DOX/Passive Melanoma cell line (B16) In vitro 
and in 
vivo 
Inhibit tumor growth, higher cellular uptake, high 
cytotoxicity 
[233] 
Alginate Gold NPs (AuNPs) & 
cisplatin/ Passive 
Colon cancer cell line (CT26) In vitro 
and in 
vivo 
Tumor growth high inhibition, enhanced survival [234] 





Promote cell cycle arrest, induce apoptosis and 
reduce the bioavailability 
[235] 
Alginate-chitosan DOX/Active Breast cancer cell line (MCF- 
7) 
In vitro Inhibit tumor progression and cellular growth [236] 
Pullulan Floate & Polyethylenimine/ 
Active 





Tumor growth inhibition [237] 





Lower cytotoxicity due to selective targeting and 
prolonged release 
[238]  
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vivo stability and the pharmacokinetics of the drug delivery system 
[161–162]. Particularly, the click conjugation presents extensive ap-
plications in molecular medicine where the cargo therapeutics bind with 
desired biomolecules including polysaccharides, antigens, nucleic acid 
sequence, mRNA, and peptides [163]. Likewise, the thiols participate in 
nucleophilic substitution with polysaccharide rings that contain halides 
as leaving group. 
Fig. 2 illustrates the various chemical modifications done on poly-
saccharides at the free –OH, and –COOH groups. The oxidation of 
polysaccharides at the –OH groups on C2/ C3 position to yield aldehyde 
groups causes a faster degradation in physiological background when 
used as controlled drug delivery carriers. The conversion of hydroxyl 
substituent to aldehyde groups provide a rotational freedom to the 
parent saccharide units, however it requires precautions such as light 
exclusion to prevent the occurrence of any side-reactions, in addition to 
limiting the concentration of the oxidant in order to achieve a controlled 
oxidation of alginate [164]. Notably, the oxidized polysaccharide 
completely degrades at the physiological pH = 7.4 at 37 ◦C, thereby 
making it an excellent drug delivery carrier [165]. The oxidation of 
polysaccharide units results in the formation of reactive aldehyde 
groups, thereby encouraging further chemical modification by reductive 
amination. The conversion takes place in the presence of suitable 
reducing agents that selectively reduce the imine intermediate, over the 
starting aldehyde group [166]. The reductive amination of poly-
saccharides with long chain alkyl amines provides amphiphilic proper-
ties to the parent polysaccharide, and lower their surface tension for a 
better physiological absorption. This drug delivery system ensures a 
better loading capacity of hydrophobic drug molecules for achieving a 
controlled drug release profile. The structural similarity of sulfated 
polysaccharide with anticoagulant heparin improves the blood 
compatibility of the test polysaccharide deliberated for drug delivery 
applications [167]. The in vitro assay for appraising the coagulation of 
human plasma in the presence of sulfated alginates suggested notable 
anticoagulant properties of the polysaccharide by targeting the intrinsic 
coagulation pathways [168]. Similarly, the esterification of poly-
saccharide acids with alkyl groups improves the hydrophobicity of the 
parent polysaccharide. Furthermore, the synthesis of alginate bis-amides 
via Ugi reaction presents an important modification of polysaccharides 
for their drug delivery applications. 
6. Polysaccharide-drug conjugates 
Numerous natural and synthetic water-soluble polymers reportedly 
exhibit conjugation with therapeutic molecule through chemical 
conjugation [169]. Pharmacokinetic investigations of drug-conjugating 
polysaccharides have documented the implications of natural and sus-
tainable polymers as robust drug delivery systems. In addition to the 
synthetic, water-soluble polymers, the natural polymers such as dextran, 
chitosan, hyaluronic acid, and cellulose seem to have a tremendous drug 
carrier potential [170]. Coupling of the hydrophobic doxorubicin (DOX) 
with the acid-cleavable hydrazone bond generated DOX-chitosan 

































































































Fig. 2. Chemical modifications on polysaccharides.  
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revealed that the chitosan-DOX conjugates with the acid-cleavable 
hydrazone bond became stable at neutral pH and dissolved at pH 5.0, 
which made a significant contribution to the eruption of DOX into HeLa 
cells. Prodrug NPs internalized rapidly to illustrate its potential appli-
cations in tumor-targeted pharmaceutical materials, contributing to a 
substantial accumulation and deposition of DOX in HeLa cells [172]. 
Simple carbohydrates, such as dextran reportedly utilize in the recom-
bination of medications. Bacterial strains, including Leuconostoc and 
Streptococcus produce copious amounts of dextran polysaccharide, 
including the primary and secondary categories of dextran that offers 
possible therapeutic conjugation regions with specific methods 
[173–174]. Reportedly, the destroying the impact of free curcumin on 
cancerous cells diminishes with time, whereas the cytostatic activity 
effects of curcumin-loaded chitosan NPs of the same concentration range 
on MCF7 cells improved significantly in the incubation period. 
Furthermore, the chemical tailoring of such materials offered selective 
and more efficient drug delivery to tumors due to the predominant 
amine and hydroxyl groups on the chitosan framework [175]. For the 
delivery of paclitaxel (PTX) and docetaxel (DTX), Skorik et al. used 
chitosan-based NP as nanocarriers. The drug-charged succinyl and glu-
taryl chitosan NPs displayed a considerable cytotoxicity towards the 
gastrointestinal cell lines and thus increased their anticancer activity 
compared to free drugs. Due mainly to a tumor-homing ligand (3-car-
boxyphenylboronic acid), the updated carboxymethyl chitosan-based 
NPs loaded with DOX demonstrated an increased accumulation con-
centrations and penetration into tumor presenting mice with H22 lung 
metastasis. This significantly reduced the mass of the H22 metastases 
lung tumor by further infiltration and aggregation of NPs in the tumor 
site. 
D-Glucuronic acid repeats and D-N-acetilglucosamin disaccharide 
conjugate to generate the hyaluronan (HA) by means of β-1,4- and β-1,3- 
glycosidic links [176]. The hyaluronate framework comprises of hy-
droxy and carboxyl groups, which participate for the conjugation with 
several drug molecules. Considering the steric hindrance and weak 
carboxyl reactivity, direct conjugation could is not preferred [177–178]. 
HA derived products that have the functional head groups such as hy-
drazine (–NH2–NH2–) improve the reactivity and drug conjugation 
efficacy. HA derivatives that require carboxylic acids to be substituted 
and functionalized also display increased drug loading with limited 
alteration in the polysaccharide structure [179]. Paclitaxel (PTX) was 
elevated in loading and reduced product toxicity relative to free PTX in 
conjugations with HA-deoxycholic acid coupled to bio-reducible cyste-
amine. The binding effects of the medication retains even after a sig-
nificant degree of replacement. Several methods reportedly cope with 
the low solubility of HA in conventional organic solvents, which ham-
pers cytotoxic conjugation reactions [180]. Those methods include the 
use of combinations of polar solvents with water, polyethylene dimethyl 
ether nanocomplexation and ion compositions of long-chain aliphatic 
cations [181]. The application of HA-drug conjugates offer a selective 
targeting of the excessive CD44 overexpressed receptors [182]. HA- 
conjugated products, including HA-mitomycin C, HA-epirubicin, HA- 
butyrates, and HA-paclitaxel present robust applications in drug de-
livery. Notably, the inhibitor of histone deacetylase demonstrated 
enhanced apoptosis activity, resulting in reduced in vivo tumor load and 
inhibition of in vitro cell development on its conjugation with HA [183]. 
The usage of N, N′-dicyclohexylcarbodiimide (DCC), and cholic acid 
derivatives (Colic acid) have modified sucrose and poly(d, l-lactic-co- 
glycolic acid) (PLSGA) through crosslink. This represents an exciting 
development for a controlled system of drug delivery for medications 
with low aqueous solubility [184]. Numerous uses featuring various 
composite hydrogels composed of polysaccharides including chitin, 
nanocellulose and chitosan offered advanced pharmaceutical delivery 
systems, enhanced regenerative medicine, tissue engineering, wound 
dressings, and water purification sorbents [185]. Chitin composites can 
be generated in spherical nanogels, in conjunction with rhodamine 123 
dye that improved the drug distribution provides applications in tissue 
engineering [186,187]. The polysaccharides conjugated to folate, fluo-
rescent functionalities maintain an optimal drug loading and drug 
release profile and present potential applications for gene therapy on 
specific positions, including cancerous cells [188]. Development of 
wound treating products based on Pectin in the recent years combined 
with cellulose and micro fibrillated cellulose offered promising results in 
vivo. The findings on animal models were encouraging, but further 
experimental tests were required for clinically success. Pectin presents 
applications in medicinal sprays as a drug carrier for the administration 
of drugs. The Pectin incorporated nasal spray drug such as fentanyl that 
relieves pain in cancer and contributes to better chemotherapy treat-
ment [189]. Fig. 3 depicts the main strategies for drug encapsulation by 
polysaccharides. 
7. Drug retention in aerogel layer and hydrogels 
Hydrogels represent 3-D hydrophilic, polymeric platforms, which 
hold potential preserve large quantities of water or biological fluids. 
Aerogels are extremely porous and provide large internal surfaces with 
exceptional drug delivery capabilities [190,191]. Almost all of these gels 
are static and brittle; however, polysaccharides form xerogels and they 
tend to generate transparent hydrogels, which spontaneously shape 
interconnected polymers. The morphological and chemical features of a 
gel rely on the consistency of the formulated aerogel. For the processing 
and distribution of chemically stable hydrogels and aerogels, the utili-
zation of hydrophilic polysaccharides and their precursors offer selec-
tive delivery of therapeutics [192,193]. The association of a 
polyelectrolyte with an opposing multivalent ion by dynamic co- 
conservation determines the properties of ionotropic hydrogels. 
Hydrogels are sensitive to different environmental conditions including 
pH, ionic strength, and temperature that influence their characteristics 
and morphology [194,195]. In certain settings, it is feasible to provide a 
long-lasting release for up to three months of nanofibrillar cellulose for 
long-term pharmaceutical applications [196]. In an attempt to improve 
the structural strength and the swelling-deswelling abilities of the 
polymer, engineered single networks to the hydrogel reduced the 
structural strength to obtain the interpenetrating polymer (IPNs). The 
IPNs constitute of the interconnecting polymer network formed by 
linking two different polysaccharides. In this context, gelatin-grafts- 
polyaniline and carboxymethyl chitosan were prepared as injectable 
coordinating IPN hydrogels with enhanced mechanical proprieties, 
crosslinked in physiological terms with oxidized dextran via the Schiff 
base formation. The evaluation of hydrogels for in vivo biocompatibility 
demonstrated a tremendous potential for drug and tissue development 
[197]. Alginate is a charged biopolymer consisting of repetitive disac-
charide units comprising of 1-4-linking β-D-mannuronic acid and α-L- 
glucuronic acid organized in separate blocks or alternating blocks at 
different proportions. Researchers have been able to establish advanced 
techniques for the distribution of natural pharmaceutical medications 
with the use of ionic and covalent combinations to form Alginate-based 
gels [198]. The redox-sensitive alginate offers applications in the con-
struction of hydrogels and nanogels using carbodiimide interconnection. 
Gels developed using redox-degradable polymers dissolve to release the 
cargo medicinal product. The poly(diallyl dimethylammonium chloride) 
(PDADMAC) conjugated with alginate provides temperature- and pH- 
sensitive hydrogels in drug delivery applications. The pH behavior of 
the hydrogels implies total swelling at pH 4, due to the ionization of the 
COOH groups in alginate, induced by electrostatic repulsion [199]. In 
comparison, polyelectrolyte complexes, PDADMAC coexist with ionized 
COOH, resulting in a diminishing swelling ratio [200]. Alongside the 
swelling attribute, investigators often build a framework for the 
controlled released of therapeutics with other features, including 
superporosity and electromechanical sensitivity. Several attempts aimed 
at the colon-targeted delivery of rabeprazole sodium by the imple-
mentation of biodegradable polymers for its mucoadhesive properties, 
generated from crosslinking O-carboxymethyl-chitosan and carbopol 
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with a Ca2+ ionic cross-linking [201]. CMSP hydrogel displays the ionic 
crosslinking with Al3+ for colon-targeted drug delivery. A CMSP 
hydrogel, filled with 5-aminosalicylic acid (5-ASA), released small levels 
of 5-ASA at stomach pH and maintained the release of drugs at colonic 
pH. The manufacturing of the polymer from industrial waste further 
promised minimization of pollutants as well as the costs of formulation 
[202]. Glutaraldehyde effectively controlled the release of Buflomedil 
hydrochloride through the Locust gum with poly(vinyl alcohol). This 
combination appropriately controlled the rate of release to short half- 
lives and improved the water solubility of the encapsulated pharma-
ceutical items [203]. The psyllium-based polymers are other modified 
polysaccharides widely used in drug delivery applications. The 
maximum effectiveness appeared at the pH 7.4 for the product buffer for 
psyllium-poly(vinyl alcohol) filled with rabeprazole sodium. The 
hydrogels possess hemocompatibility, which suggests their application 
in pharmaceutical goods for the treatment of bloating ulcers [204]. 
8. Polysaccharide drug-loaded through self-assembling 
Hydrophilic polysaccharide backbones construct the self-assembling 
frameworks, such as niosomes and liposomes, when they are introduced 
to hydrophilic polymers [205–207]. The self-assembly of hydrophobic 
polysaccharide formulates from the polymer backbones treated with 
hydrophobic sections of hydrophilic polysaccharides containing hy-
droxy, amino or carboxy groups that eventually form amphiphilic 
macromolecules. This solubilizes the hydrophobic drugs molecules in 
the self-assembling drug delivery polysaccharides. The factors such as 
fluctuations in pH, ionic intensity, and temperature further determine 
the drug release from these polysaccharides [208]. Self-assembled 
nanoparticles in hydrophilic polysaccharide frameworks such as 
amylose, guar gums, pectin, chitosan, dextran and rubber beans offer 
wider applications in the delivery of hydrophobic drugs at the target 
site. The polysaccharides offer an ideal platform for colon-target dis-
tribution since it shows high stability in the stomach pH, as compared to 
the intestine physiological environment as the colon microbiota induces 
Fig. 3. Drug loading strategies by Polysaccharide nanoparticles.  
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polysaccharide degradation and eventually release the therapeutics 
payload into the colon [209]. Polysaccharide-based NPs such as chitosan 
armed with therapies like paclitaxel, ibuprofen, and amphiphilic doxo-
rubicin (DOX) improve the overall therapeutic effect of the drug. Amino 
groups on Chitosan participate in the grafting of hydrophobic groups 
through acylation with acyl chloride or anhydride acid and ultimately 
interconnected with deoxycholic acid. Advanced applications such as 
plasmid DNA transfection with deoxycholic groups-acid NPs (160 nm) 
was reported in COS-1 cells [210]. Dextran, often considered the self- 
assembled nanosized drug carrier, offers the grafting of several bio-
molecular moieties such as bile acids, normal amphiphilic steroids, and 
lauryl strands. Azido-modified dextran NPs mixed with mannose 
showed an improved cellular internalization for the delivery of thera-
peutic agents. Addition of acrylic acid to dextran generated pH-sensitive 
NPs between 40 and 140 nm diameter [211]. The modified dextran 
effectively improves the absorption of DOX, hence proving to be a viable 
transporter for DOX. Dextrin nanogel filled with DOX minimizes the 
toxicity of the drug towards normal human cells by reducing the ther-
apeutics side effects. Chemical transformation of HA to form NPs in the 
size range 200–400 nm, comparable to dextran and chitosan conjugated 
with 5-β cholinic acid offered highly effective treatment of inactive 
CD44 tumors. HA shapes amphiphilic chain copolymers when cova-
lently linked to the poly(γ-benzyl l-glutamate) component [212]. Not 
only were these nanoparticulates elevated the cellular uptake by endo-
cytosis, but they have also increased drug toxicity in the target KB cells 
[213]. The usage of starch or cellulose-based drug delivery nano-
particles also improved their solubility in the organic solvents by the 
introduction of chemical modifications on the hydroxy and carboxyl 
groups. These approaches further improved the drug loading capacity 
onto these nanocarriers by conjugating with the functional head groups 
on the polysaccharide surface [214]. 
Therefore, the polysaccharide offer a fascinating choice as polymeric 
material in drug delivery due to biodegradability and biocompatibility. 
The application of polysaccharide in drug delivery is growing very fast 
as it provides a safe, nontoxic and tunable alternates of synthetic poly-
mers for the same purpose. The diverse chemical structures, functional 
groups and physicochemical properties are making polysaccharides a 
suitable candidate in drug delivery [239,240]. 
9. Polysaccharide based controlled release and targeted 
formulations 
Unlike the synthetic hydrophilic polymers, polysaccharide possess a 
variety of hydrophilic functional groups on its structure like –OH, 
–COOH, and –NH2 group which are responsible for water absorption 
and further swelling of polysaccharide. These groups grant a variety of 
functional capability to the polysaccharide-based systems such as bio-
adhesion and control release property. Controlled release property of 
polysaccharide-based drug delivery systems has been explored exten-
sively for achieving a prolonged delivery of variety of therapeutics such 
as chemotherapeutics, proteins, peptides, nucleic acid and many more 
[1]. The control release of therapeutics from the swelled polysaccharide 
depends on the porosity or degree of swelling, further regulated by 
certain parameters like pH, temperature, ionic strength and electric 
fields [241]. Several polysaccharides present controlled release and 
target specific delivery applications.  
1. Chitosan 
It is a linear polysaccharide obtained from the exoskeleton of ar-
thropods such as crabs, lobster, and shrimp and cell walls of fungi. It is 
available in variety of molecular weight and degree of acetylation, 
which control its physical and biological property. Hydroxy and amino 
groups on the chitosan are involved in making intra- and intermolecular 
hydrogen bonds. The pH dependent protonation of amino group leads to 
swelling of the Chitosan to form three- dimension structure gel at pH 
lower than the pKa [242]. Various chitosan salts such as chitosan 
palmitate and chitosan laurate exhibit different degrees of swelling, and 
thus drug release from the variety of dosage form. The presence of pri-
mary amines in chitosan is responsible for its biological activity such as 
antimicrobial, anticancer. Chitosan nanoparticles showed greater anti-
microbial activity against Staphylococcus aureus, Klebsiella pneumoniae, 
Pseudomonas aeruginosa, and Escherichia coli compared to parent chito-
san and chitin [243]. Chitosan-based controlled release and targeted 
formulations developed so far are compiled in Table 2.  
2. Alginate 
It is an extensively studied linear polysaccharide derived from brown 
seaweed (Macrocystis pyrifera, Laminaria hyperborean) and from some 
certain bacteria belonging to the family Pseudomonas and Azotobacter. 
Similar to chitosan, aginate also form a thick gel at low pH, which served 
as a barrier for controlled release of therapeutics. Additionally, alginate 
also form thick gel with certain polyvalent cations (Ca2+ and Na+) due to 
crosslinking of carboxylic groups of polysaccharide structure. Due to the 
bioadhesion property of alginate, it offers targeted drug delivery ap-
plications. So far, this polysaccharide has been explored for variety of 
formulations including matrix tablet [244], microspheres [245], pellets 
[246] and nanoparticles for targeted and functionalized delivery [247] 
(Table 2). The combination of S-nitroso-mercaptosuccinate (a nitric 
oxide donor) and green tea synthesized silver nanoparticles incorpo-
rated into alginate hydrogel showed synergistic antimicrobial activity 
against Staphylococcus aureus, Escherichia coli and Streptococcus mutants 
compared to individual compounds [248].  
3. Pectin 
Pectin is a complex polysaccharide present almost one third of the 
dry cell wall material of most of the plants. These are higher molecular 
weight (50,000 and 150, 000 Da) polysaccharides consist α-(1–4) linked 
esterified D-galacturonic moiety. Various physicochemical parameters 
of pectin like solubility, viscosity and gelling properties depends upon 
the degree of methyl esterification of D-galacturonic moiety. Depending 
upon the degree of esterification two types of pectin are commercially 
available; highmethoxyl pectins (degree of esterification > 50) and low 
methoxyl pectins (degree of esterification < 50) [249]. Various plant 
pectins reportedly exhibit applications as controlled release excipients 
in tablet, hydrogels and pellets. Additionally, plant pectins offer appli-
cations in colon targeted drug delivery due to their biodegradation po-
tential by colonic microflora [250]. The pectin polysaccharide from 
Ulmus pumila L. (PPU) possess potent anti-inflammatory activity. It was 
observed that the selenized-PPU inhibit lipopolysaccharide (LPS)-stim-
ulated nitric oxide release by targeting the protein expression of 
inducible nitric oxide synthase in murine macrophage cell line RAW 
264.7 [251].  
4. Guar Gum 
It is a high molecular weight linear polysaccharide obtained from the 
seeds of the plant Cyamopsis tetragonoloba. The polysaccharide consist of 
linear chain of (1 → 4)-linked β-D-mannopyranosyl units with (1 → 6)- 
linked α-D-galactopyranosyl residues as side chains with the ratio of 
mannose to galactose units as 2:1. This polysaccharide swells in polar 
solvent and thus has been widely explored for various pharmaceutical 
applications. Addition of ionic and non-ionic additives (sodium chloride 
and glycerin) could change the swelling and erosion property of poly-
saccharide for offering a variety of applications [14]. This poly-
saccharide serves as tablet binder sustain release polymer and viscosity 
enhancers. This polysaccharide has become the primary choice as 
excipient in colon specific oral product as it remain indigestible in upper 
GIT and completely degrades by the colonic microflora [252]. Gamal- 
Eldeen prepared guar gum C-glycosylated derivative (GG) and its 
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sulphated derivative (SGG) to investigate its anti-cancer and anti- 
inflammatory potency. It was observed that GG inhibits cytochrome 
P450 1A (a carcinogen activator enzyme) and stimulated the 
carcinogen-neutralizing enzymes such as glutathione-S-transferases. 
Furthermore, both GG and SGG were able to exert anti-inflammatory 
by reducing the release of nitric oxide and tumor necrosis factor-alpha 
in LPS induced RAW264.7. GG and SGG also inhibited the prolifera-
tion of human hepatocellular carcinoma cells (Hep G2), while only SGG 
was particularly toxic for MCF-7 [253]. Table 2 presents the selected 
applications of guar gum as pharmaceutical excipients.  
5. Starch 
Starch is a naturally available polysaccharide obtained from plants. 
Its characteristic properties such as biotolerance and non- 
immunogenicity for human use, and easy availability make it a 
commonly used polymers/pharmaceutical excipient [254,255]. In 
comparison to other polymers such as gum and cellulose, starch does not 
need to undergo excessive purification, as they are relatively pure. 
Structurally, starch has two different glucan chains a. amylose (linear 
polymer) and b. amylopectin (branched polymer) representing 98–99% 
of the dry weight. In the production of capsules and tablets, starch is 
widely utilized as a lubricant, diluent, binder and disintegrant whereas it 
is also commonly employed for variety of specialized drug delivery 
applications, for example delivery of specialized drug and targeting 
specific parts of human body [256]. The microsphere of oregano 
essential oil prepared by starch-based material utilizing supercritical 
fluid technology showed superior antioxidant capacity (in terms of ox-
ygen radical absorbing capacity) and stability. Starch-based drug carrier 
systems present high efficacy in the oral delivery of insoluble drugs 
[257]. Luo et al. encapsulated curcumin into starch microparticles and 
the formulation showed enhanced stability against photodegradation 
and oxidative modification. Furthermore, the size of curcumin starch 
microparticles was possible to control accurately from 0.3-2 μm by 
altering the rate of debranching reaction that caused alteration of 
release characteristic of curcumin. These observations suggested the 
management of the release site by modifying the crystallinity or size of 
microparticles [258]. Alp et al., formulated starch nanoparticles for the 
delivery of epigenetic drugs CG-1521 for breast cancer that inhibits 
histone deacetylase. The nanoparticles formulation showed decrease 
release rate of CG-1521 allowing remarkable cytotoxicity against MCF-7 
breast cancer cell as compared to free CG-1521 [259]. 
10. Polysaccharides as emulsion stabilizers 
The amphiphilic nature of chemically modified polysaccharides 
causes their adsorption at the interface of oil and aqueous solvents that 
results in the stabilization of the emulsion [269]. This property of 
polysaccharides proved highly beneficial for the delivery of lipophilic or 
non-polar therapeutics at their target site [270]. As such, the native 
cellulose does not offer emulsion stabilization due to its non-solubility in 
water. The chemically modified cellulose not only improves its aqueous 
solubility but also affords the stabilization of the emulsion [271]. The 
large size of polysaccharides slows down their adsorption process 
compared to the small sized surface-active agents. Mainly, the 
polysaccharide-based emulsifiers mainly base on pectins, gum arabic, 
galactomannans, and cellulose. Cellulose and starch promote the 
emulsion stabilization only after their chemical modification however; 
the polysaccharides such as gum arabic and pectins endowed with 
covalently linked glycoproteins possess intrinsic ability for the stabili-
zation of the emulsion. In addition, the polysaccharides such as xanthan 
gum, carrageenan, alginates, hyaluronan, chitosan, and alginates that 
display trivial interfacial activity offer the eulsion stabilization via 
thickening, gelling, and structuring [272]. The structural relationship 
between chitin-based nanomaterials to that of cellulose results in a 
similar amphiphilic behavior for potential applications as stabilizers of 
oil-in-water Pickering emulsion. Starch microgranules demonstrate 
similar applications however; the nanocrystals and nanospheres of 
starch exhibit a limited stabilization of the emulsion [273]. Yan et al. 
reported the stabilization of Pickering emulsions droplets by nano-
crystals of bacterial cellulose for hydrophobic drug delivery of Alfa-
calcidol. The irreversible adsorption of bacterial cellulose nanocrystals 
at the oil-water interface of Pickering emulsions prevented the coales-
cence of the droplets. The emulsion showed Ostwald ripening in the 
alginate solution. The interfacial assembly of the amphiphilic bacterial 
cellulose nanocrystals and the hydrogel shells of the alginate beads 
generated by the external gelation led to the achievement of efficient 
loading and a controlled release of Alfacalcidol. The release mechanism 
of Alfacalcidol from the composite beads followed non-Fickian trans-
port. The alginate composite beads demonstrated minimal toxicity that 
further proved beneficial for drug delivery applications. Koshani et al. 
presented the lipophilic drug delivery applications via natural emulgel 
obtained from dialdehyde cellulose crosslinked with chitosan. The de-
livery of the lipophilic compound β-carotene occurred using an 
embedded oil-in-water emulsion. The lipophilic β-carotene loaded in the 
Table 2 
Different polysaccharides explored for the sustained release of pharmaceuticals.  
Polysaccharide Formulation Drug Remark Ref. 
Chitosan Oral Tablet Sodium valproate Extended release behavior of embedded drug upto 24 h [260] 
Hydrogel Caffeine, Ascorbic acid, and 5- 
fluorouracil 
Extended drug release upto 24 h [261] 
Bioadhesive vaginal tablet Fluconazole Delayed release with T80 17.4 h [262] 
Dry powder inhaler Rifampicin and Rifabutin Sustained release at pulmonary region, upto 12 h for rifampicin and up to 96 h 
for rifabutin 
[263] 
Alginate Matrix Tablet Metronidazole Effect of particle size of drug, additive used, and pH of medium was evaluated 
on drug release 
[244] 
Microspheres Blue dextran Extended drug release upto 24 h [245] 
Pellets Theophylline Incorporation of Ca salt prolong the drug release [246] 
Nanoparticles Cisplatin Folate conjugation provide selectively taken up by HNE-1 cells and Hep-2 cells [247] 
Pectin Colon specific microparticles Methotrexate Microparticles were prepared by ion gelation method [250] 
Nanoparticles Diclofenac sodium Nanoparticles were able to release the drug for prolonged period of time [264] 
Pectin coated liposome Vitamin C Significant improvement in permeation [265] 
Guar gum Colon Tablet Metronidazole More availability of drug at colon [252] 
Folic acid conjugated 
nanoparticles 
Methotrexate Enhanced uptake of delivery systems by colorectal cancer cells [266] 
Nanoaggregates Isoniazid and Rifampicin Formulations shows enhanced local action due to sustained release [267] 
Hydrogel Rifampicin Enhance mucoadhesion thus better efficacy [268] 
Starch Microspheres Oregano essential oil High antioxidant activity values and stability [257] 
Microparticles Curcumin Enhance stability against photodegradation and chemical oxidation [258] 
Nanoparticles CG-1521 (histone deacetylase 
inhibitor) 
Decrease release rate of CG-1521 allowing remarkable cytotoxicity against 
MCF-7 breast cancer 
[259]  
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oil-phase showed 20% release in stomach after passing safely through 
the oral cavity. Furthermore, 50% of β-carotene released in the in-
testines after 4 h in the presence of emulgel thereby indicating its 
application as oral delivery vehicle [274]. 
11. Clinical trials on Polysaccharide based drug delivery 
systems 
Riedl et al. performed phase I clinical trials on the dextran- 
conjugated doxorubicin on 13 patients at a starting dose of 40 mg/m2 
that led to the development of WHO grade IV thrombocytopenia in 2/2 
patients. Whereas, the WHO grade IV hepatotoxicity, and WHO grade III 
cardiotoxicity appeared in patients with preexisting heart ailments. 
Lowering of the dose to 20 mg/m2 further decreased the existence of 
thrombocytopenia. However, the hepatotoxicity persisted. Further 
reducing the dose to 12.5 mg/m2 caused marked reduction in the ma-
lignancy fibrous histiocytoma for up to 4 months [275]. Soepenberg 
et al. performed phase I clinical trials on DE-310, a camptothecin analog, 
and a carboxymethyldextran polyalcohol carrier, in the patients with 
advanced solid tumors. The DE-301 drug delivery system reportedly 
released DX-8951 drug slowly, while maintaining a sustained release. 
This prolonged the drug exposure at its deliberated tumor site. Some 
patients showed partial-to-complete remission of metastatic adenocar-
cinoma at dose 7.5 mg/ m2 [276]. Kim et al. conducted phase II clinical 
trials on holmium 166/ chitosan complex for the effective treatment of 
hepatocellular carcinoma. The percutaneous administration of the 
nanosystem caused a complete tumor necrosis in 31/40 patients after 2 
months period. However, a long-term follow-up period indicated 
recurring of tumor in 28 patients. The polysaccharide based drug de-
livery system proved beneficial for the treatment of small hepatocellular 
carcinoma by performing local ablative procedure [277]. Pinnix et al. 
performed single-blind randomized phase III clinical trials on topical 
hyaluronic acid after adjuvant radiotherapy for breast cancer. The 
topical hyaluronic based gel did not proved effective for the treatment of 
grade 2 dermatitis following radiotherapy [278]. Pritchard et al. re-
ported phase II clinical trials on oligosaccharide polymer therapy for 
modification of mucus barrier of COPD. The binding of the oligosac-
charide caused alteration in the surface charge, porosity, and 3-D mucin 
networks in sputum of patients with cystic fibrosis, and its inhalation in 
patients caused effective deposition in lungs and altered the viscoelas-
ticity of the cystic fibrosis sputum [279]. 
12. Conclusion and future perspectives 
The polysaccharide based drug-delivery vehicles traversed a long 
journey for the controlled release of pharmaceuticals at the target site 
with minimized ensuing side effects caused by the customary delivery 
vectors. The biodegradability and trivial immunogenicity of the 
polysaccharide-based drug delivery vehicles makes them the material of 
the future. The controlled release profile offers improved drug phar-
macokinetics thereby leading to ameliorated local action, and effec-
tivity. As such, the polysaccharides present the first-in-class drug 
delivery system ‘Novochizol’ for the delivery of COVID-19 drugs. The 
system comprises of biodegradable and biocompatible chitosan nano-
particles that strongly adhere to the lung epithelium and offers a sus-
tained drug-release. Similarly, the recent discovery of helical V-amylose 
as advanced drug delivery system further validated the precedence of 
polysaccharides as drug delivery vehicles. The helical morphology of V- 
amylose offers drug encapsulation in the helix groves while interacting 
with the functional head groups. This system proved highly advanta-
geous for the delivery of indomethacin, diclofenac, and aspirin with 
enhanced gastric tolerance. The conjugation of polysaccharides with 
metal nanoparticles with unique physicochemical profile in the form of 
optical, electronic, magnetic, and surface properties provide nanoprobes 
that present a sturdy candidature in bioimaging of the effected site, 
while delivery the cargo pharmaceutical at the same time. The 
development of multicompartmental microspheres based on poly-
saccharides revolutionized bioengineering and multi-drug delivery with 
high precision. The coaxial electrospun fiber membranes based on 
polysaccharides transformed the plant grafting techniques and effec-
tively managed the plant tissue injury due to their high mechanical and 
tensile strength. The biological phenomenon such as wood degradation 
by brown-rot fungi led to the development of bioinspired, core shell 
cellulose microparticles for the light-triggered release of anticancer 
drugs. Furthermore, the stabilization of Pickering emulsions by chemi-
cally modified polysaccharides play a significant role in the lipophilic 
drug delivery applications, and targeted delivery of various pharma-
ceuticals and bioactive ingredients. 
Despite several benefits, the polysaccharide-based formulations 
suffer limitations such as susceptibility towards microbial contamina-
tion, uncontrolled hydration rate, and reduced viscosity during storage. 
To overcome these limitations, it mandates the modification of natural 
polysaccharides via cross-linking, grafting, and blending with natural 
and synthetic polymers to improve their physicochemical profile. 
Similarly, the limited knowledge about the mechanism of drug release 
by polysaccharides, and permeation enhancement decelerates the pro-
gressive developments in polysaccharide-based drug delivery systems. 
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